DEXCOM INC (DXCM) Form 10-Q — Jul 30, 2026
DexCom reported strong second quarter fiscal 2026 results, with revenue increasing 13% year-over-year to $1.31 billion and net income rising 39% to $249.1 million. The growth was primarily driven by increased sales volume of disposable sensors and the adoption of the G7 15 Day system, alongside improved manufacturing efficiencies and a more favorable product mix. The company generated $794.8 million in operating cash flow during the first six months of the year and ended the quarter with $1.95 billion in total liquidity.
Key figures
- Eps
- 0.64
- Eps Beat
- 42% yoy growth
- Revenue
- 1308.4
- Net Income
- 249.1
- Revenue Yoy
- 13%
- Cash Position
- 1105
- Shares Outstanding
- 377,360,765
- Total liquidity
- 1947
- Gross profit margin
- 63.4%
- Share repurchases 6m
- 600
- Operating cash flow 6m
- 794.8
Price after filing
Close on the filing date to close N calendar days later (from $74.85). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.